ARCHIVES

Raub Briefs Councils On Women’s Health, Cost Containment

This article is from The Cancer Letter archive.

Vol. 16 No. 39 | October 12, 1990

Download PDF Visit The Full Archive

Related Articles

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Garb’s Questions, Answers About Cancer Program

December 12, 1980

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

NCI Contract Awards.

February 18, 2000